Tudor Investment Corp
NGM

Tudor Investment Corp’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Tudor Investment Corp’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,147
Closed -$40K – 2927
2024
Q1 		$40K Hold
25,147
– – ﹤0.01% 2122
2023
Q4 		$21.6K Hold
25,147
– – ﹤0.01% 2281
2023
Q3 		$26.9K Sell
25,147
-14,806
-37% -$30.6K ﹤0.01% 2202
2023
Q2 		$103K Hold
39,953
– – ﹤0.01% 2292
2023
Q1 		$163K Buy
39,953
+3,765
+10% +$17.4K ﹤0.01% 2206
2022
Q4 		$182K Sell
36,188
-4,199
-10% -$26.3K ﹤0.01% 2150
2022
Q3 		$528K Buy
40,387
+871
+2% +$13.2K 0.01% 1362
2022
Q2 		$507K Buy
+39,516
New +$547K 0.01% 1263

Tudor Investment Corp's NGM Position: Q2 2024 in Review

Tudor Investment Corp sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 25,147 shares — an estimated $40K sold.

Tudor Investment Corp first reported a position in NGM in Q2 2022 and held it in 8 quarters. The position peaked at $528K in Q3 2022. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Tudor Investment Corp reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 25,147 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $40K.
  • Tudor Investment Corp first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Tudor Investment Corp's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $528K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.